DarioHealth Corp DRIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
-
Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives
-
DarioHealth Reports Second Quarter 2026 Financial Results
-
Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
-
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
-
Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience
-
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
Trading Information
- Previous Close Price
- $5.80
- Day Range
- $5.33–6.37
- 52-Week Range
- $5.33–16.50
- Bid/Ask
- $2.19 / $8.06
- Shares Outstanding
- 9.80M
- Market Cap
- $53.11M
- Volume/Avg
- 11,303 / 24,803
Key Statistics
- Price/Earnings (Normalized)
- 0.61
- Price/Sales
- 1.91
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 165
- Website
- https://www.mydario.com
Valuation
|
Metric
|
DRIO
|
|---|---|
Price/Earnings (Normalized) | 0.61 |
Price/Book Value | 0.72 |
Price/Sales | 1.91 |
Price/Cash Flow | — |
Price/Earnings
DRIO
Financial Strength
|
Metric
|
DRIO
|
|---|---|
Quick Ratio | 1.89 |
Current Ratio | 2.31 |
Interest Coverage | −6.93 |
Quick Ratio
DRIO
Profitability
|
Metric
|
DRIO
|
|---|---|
Return on Assets (Normalized) | −31.67% |
Return on Equity (Normalized) | −52.34% |
Return on Invested Capital (Normalized) | −31.99% |
Return on Assets
DRIO
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|<n&hBL#w | LOCK|Gzs | $48B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|?!<zC | $12B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|Y$ | $12B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|?&RN | $12B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|>&g%& | $12B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|z&@p | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|l%n&! | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|@b>$k | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|sqQ& | $8B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|%< | $5B |
United States